Neurosense Therapeutics LTD. 6-K Filing
Ticker: NRSN · Form: 6-K · Filed: Apr 3, 2026 · CIK: 0001875091
Sentiment: neutral
Filing Stats: 271 words · 1 min read · ~1 pages · Grade level 10.7 · Accepted 2026-04-03 09:27:09
Filing Documents
- ea0285059-6k_neuro.htm (6-K) — 12KB
- ea028505901ex99-1.htm (EX-99.1) — 12KB
- ea028505901_ex99-1img1.jpg (GRAPHIC) — 27KB
- 0001213900-26-039734.txt ( ) — 64KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. NeuroSense Therapeutics Ltd. Date: April 3, 2026 By: /s/ Alon Ben-Noon Alon Ben-Noon Chief Executive Officer 3